InsidersTradesSigma
Kaleido Biosciences, Inc.: management transactions · United States · SEC (Form 4)
SEC:kaleido-biosciences-inc-fc891bUS·SEC (Form 4)Mcap 0M€Healthcare
Browse the full management transaction log of Kaleido Biosciences, Inc., a listed equity based in United States. Shares trade on US US, under the oversight of SEC (Form 4). Operating in the Healthcare sector, Kaleido Biosciences, Inc. has logged 2 public disclosures. Market capitalisation: €4k. The latest transaction was filed on 2 March 2022 (Retenue fiscale). Among the most active insiders: van Hylckama Vlieg Johan. All data is openly available.
2
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2021 · cache
0.00 €
Analyst consensus
Income statement
Revenue1.1 M€
Net income−90.3 M€-8178.3% margin
Valuation
P/Book0.0x
Beta38.51
Balance sheet & cash
Market cap4 k€
Total debt21.7 M€
Free Cash Flow−78.2 M€
Debt / Equity205%
Profitability & ownership
ROE-580.6%
ROA-99.9%
% insiders0.0%
% institutions0.1%
Last declaration on 2 March 2022
Declarations0 total
No declarations found
0 of 0 declarations